DACS
GSK icon

Dymon Asia Capital (Singapore)’s GSK GSK Stock Holding History

Dymon Asia Capital (Singapore)’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60,200
Closed -$3.32M – 274
2026
Q1 		$3.32M Buy
+60,200
New +$3.26M 0.34% 84
2025
Q4 		– Sell
-40,000
Closed -$1.73M – 279
2025
Q3 		$1.73M Buy
40,000
+13,500
+51% +$527K 0.18% 118
2025
Q2 		$1.02M Buy
26,500
+8,500
+47% +$325K 0.14% 114
2025
Q1 		$697K Buy
+18,000
New +$659K 0.16% 96

Other funds holding GSK

JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
MIP
Mondrian Investment Partners London, United Kingdom $6.48B AUM 18.36% 1-Year Est. Return
MHI
Miller Howard Investments Kingston, New York $3.77B AUM 23.82% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
TNB
Thomasville National Bank Thomasville, Georgia $1.82B AUM
AssetMark Inc
AssetMark Inc Concord, California $58.2B AUM 22.78% 1-Year Est. Return
AA
ABC Arbitrage Paris, France $926M AUM 45.9% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $8.23B AUM 17.62% 1-Year Est. Return
CFM
Capricorn Fund Managers London, United Kingdom $1.27B AUM 70.17% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return

Dymon Asia Capital (Singapore)'s GSK Position: Q2 2026 in Review

Dymon Asia Capital (Singapore) sold out of GSK (GSK) in Q2 2026, closing a stake of 60,200 shares — an estimated $3.32M sold.

Dymon Asia Capital (Singapore) first reported a position in GSK in Q1 2025 and held it in 4 quarters. The position peaked at $3.32M in Q1 2026. 439 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Dymon Asia Capital (Singapore) reported no remaining GSK position as of Q2 2026 after selling out during the quarter.
  • Dymon Asia Capital (Singapore) sold 60,200 GSK shares in Q2 2026, an estimated $3.32M.
  • Dymon Asia Capital (Singapore) first reported a position in GSK in Q1 2025 and held it in 4 quarters.
  • Dymon Asia Capital (Singapore)'s GSK position peaked at $3.32M in Q1 2026.
  • 439 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Dymon Asia Capital (Singapore)'s 13F filing for Q2 2026, filed 23 Jul 2026.